Avidity Partners , BlackRock , Pura Vida Investments , RA Capital Management and Sands Capital Management ’s $220m venture financing deal with eXo Imaging was the medical devices industry’s biggest big data deal of Q3 2021 as big data deals worth $1bn were announced globally in the quarter, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked an increase of 50.2% over the previous quarter and a drop of 66.9% when compared with the last four-quarter average of $3.08bn.

In terms of number of big data deals, the sector saw a drop of 16.52% with 24 deals in Q3 2021 against the average of 28.75 deals in the last four-quarters.

In value terms, Asia-Pacific led the activity with big data deals worth $404.24m.

medical devices industry big data deals in Q3 2021: Top deals

The top five medical devices industry big data deals accounted for 74.2% of the overall value during Q3 2021.

The combined value of the top five big data deals stood at $759.1m, against the overall value of $1bn recorded for the quarter.

The top five medical devices industry big data deals of Q3 2021 tracked by GlobalData were:

1) Avidity Partners,BlackRock,Pura Vida Investments,RA Capital Management and Sands Capital Management $220m venture financing deal with eXo Imaging

2) The $200m acquisition of Zebra Medical Vision by Nano-X Imaging

3) CCB Trust,Chinese Fund of Funds (FOF),Goldman Sachs Asset Management,Springhill Fund,TopoScend Capital and Zhongguancun M&A Fund $139.1m venture financing deal with Beijing Infervision Technology

4) The $100m venture financing of Pulse Medical Imaging Technology (Shanghai) by Boyu Capital Consultancy,GL Ventures,Goldman Sachs Group,Insight Capital,Koninklijke Philips and Linden Asset Management

5) Hibercell $100m acquisition deal with Genuity Science